KennethResearch published a reporttitled “Epilepsy Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview ofthe global epilepsy market in terms of market segmentation by end-use,
treatment & diagnosis and by region.
Further,for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global epilepsymarketisexpected to grow at ~8% CAGRover the forecast period, i.e., 2022-2031. The market is segmented bytreatment & diagnosis into treatment and diagnosis, out of these, the
diagnosis segment is anticipated to hold the largest share in the market over
the forecast period. This can be attributed to the early diagnosis of epilepsy
disorder through blood and imaging tests.
Ascompared to the younger population, the aged population is more inclined to
epilepsy disorder. Therefore, an increase in the aged population is expected to
drive the growth of the global epilepsy market.Moreover, there has been growing awareness among the people related to epilepsy
which is another factor that is anticipated to increase the growth of the
global epilepsy market.
Geographically,the global epilepsy marketissegmented into five majorregions including North America, Europe, Asia Pacific, Latin America and Middle
East & Africa region. Out of them, the market in the Asia Pacific region is
estimated to witness modest growth during the forecast period owing to the
increase in the aged population, the rise in spending on research and
development, and a surge in healthcare expenditure.
Theresearch is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
Rise in the Epilepsy Disorder Cases to Drivethe Growth of the Market
As per the World Health Organization, around50 million individuals suffer from epilepsy worldwide, with approximately 80%
of them living in middle- and low-income nations.
There has been a rise in the number of epilepsydisorder cases worldwide, mainly in low-and middle- income nations where there
are fewer facilities for healthcare. Moreover, awareness related to epilepsy is
increasing across the globe, contributing to the rise in the number of cases.
Therefore, the rise in the number of epilepsy disorder cases is anticipated to
surge the growth of the global epilepsy market.
However,increasing cost of medicine and a lack of skilled healthcare workers are expected to operate as keyrestraint to the growth of global epilepsymarket over the forecast period.
Thisreport also provides the existing competitive scenario of some of the key
players of the epilepsy marketwhich includes company profiling of NeuroPace, Inc., Pfizer Inc., LivaNova PLC, Abbott., JazzPharmaceuticals plc (GW Pharmaceuticals), Novartis AG, Johnson & Johnson
Services, Inc., Medtronic, Eisai Co., Ltd., GlaxoSmithKline plc., and others. Theprofiling enfolds key information of the companies which encompasses business
overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the epilepsy market that will helpindustry consultants, equipment manufacturers, existing players searching for
expansion opportunities, new players searching possibilities and other
stakeholders to align their market centric strategies according to the ongoing
and expected trends in the future.
Request Report Sample@ https://www.kennethresearch.com/sample-request-10085881
Kenneth Research is a leading service provider forstrategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for moreInfo:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609